Saif, Muhammad Wasif http://orcid.org/0000-0001-8154-957X
Becerra, Carlos R.
Fakih, Marwan G.
Sun, Weijing
Popovic, Lazar
Krishnamurthi, Smitha
George, Thomas J.
Rudek, Michelle A.
Shepard, Dale R.
Skopek, Jiri
Sramek, Vladimir
Zaric, Bojan
Yamamiya, Ikuo
Benhadji, Karim A.
Hamada, Kensuke
He, Yaohua
Rosen, Lee
Funding for this research was provided by:
Taiho Oncology, Inc.
Taiho Pharmaceutical Co., Ltd.
Article History
Received: 29 January 2021
Accepted: 30 May 2021
First Online: 7 June 2021
Declarations
:
: M.W.S. reports research funding from Incyte, Lexicon, NGM Bio, Nouscom, Tesaro, and Yivia. C.R.B. is part of the speaker bureau for Taiho Oncology Inc. M.G.F. received research grant funding (to institution) from Amgen, AstraZeneca, and Novartis; has served on the advisory board of Amgen, Array Biopharma, Bayer, and Pfizer; is part of the speakers bureau for Amgen and Guardant360, and reports honoraria from Amgen. M.A.R. received research funding from Taiho Oncology, Inc, during the conduct of the study and from Celgene Corporation and the National Cancer Institute, outside the submitted work. K.H., I.Y., K.A.B., and Y.H are employees of Taiho Oncology, Inc. K.A.B. is a former employee and a stockholder of Eli Lilly. L.R. received research funding from Taiho Oncology, Inc. W.S., L.P., S.K., T.J.G., D.R.S., J.S., V.S., and B.Z have no financial disclosures to report.
: This study was performed in line with the Declaration of Helsinki. Approval was granted from the review board or ethics committee of each institution.
: Informed consent was obtained from all individual participants included in the study.